Cargando…
Prevalence of COVID-19 Risk Factors and Risks of Severe Acute Respiratory Disease are Markedly Higher in Patients with Symptomatic Peripheral Arterial Occlusive Disease
Autores principales: | Peters, Frederik, Marschall, Ursula, Behrendt, Christian-Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Vascular Surgery. Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934833/ https://www.ncbi.nlm.nih.gov/pubmed/33846074 http://dx.doi.org/10.1016/j.ejvs.2021.02.055 |
Ejemplares similares
-
Antithrombotic Treatment Patterns of Patients with Symptomatic Peripheral Arterial Occlusive Disease in Germany: Evidence from Health Insurance Claims Data
por: Peters, Frederik, et al.
Publicado: (2022) -
Long‐Term Effectiveness and Safety of Initiating Statin Therapy After Index Revascularization In Patients With Peripheral Arterial Occlusive Disease
por: Peters, Frederik, et al.
Publicado: (2020) -
A retrospective cohort study on the provision and outcomes of pharmacological therapy after revascularisation for peripheral arterial occlusive disease: a study protocol
por: Peters, Frederik, et al.
Publicado: (2020) -
Prevalence and Risk Factors for the Peripheral Neuropathy in Patients with Peripheral Arterial Occlusive Disease
por: Kim, Young Ae, et al.
Publicado: (2014) -
Sex Disparities in Long-Term Mortality after Paclitaxel Exposure in Patients with Peripheral Artery Disease: A Nationwide Claims-Based Cohort Study
por: Behrendt, Christian-Alexander, et al.
Publicado: (2021)